Effects of Early Physical Therapy and Follow-Up in Acute Severe Coronavirus Disease 2019 Pneumonia: A Retrospective Observational Study.
COVID-19
SARS-CoV-2
early physical therapy
pulmonary rehabilitation
rehabilitation
Journal
Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
01
2022
accepted:
10
03
2022
entrez:
28
4
2022
pubmed:
29
4
2022
medline:
29
4
2022
Statut:
epublish
Résumé
Rehabilitation in subjects with severe coronavirus disease 2019 (COVID-19) pneumonia has been widely recommended. However, data regarding the starting time of rehabilitation, subjects and healthcare workers' safety, as well as rehabilitation program features are limited. We aimed to assess the safety and characterize the effect of early and non-early physiotherapy on severe COVID-19 pneumonia subjects. A retrospective cohort study, including a consecutive sample of surviving subjects admitted to an acute care hospital due to severe COVID-19 pneumonia from March 13th to May 15th of 2020, is made. Subjects were separated into three groups: non-physical therapy, early physiotherapy (onset <7 days of admission), and non-early physiotherapy. Subject and therapist safety and length of hospital stay were the main evaluated outcomes. A total of 159 subjects were included (72% men; median age 62 years). Rehabilitation was performed on 108 subjects (32 early and 76 non-early physiotherapies). The length of hospital stay was 19 [interquartile range (IQR) 36.25] and 34 days (IQR 27.25) ( Rehabilitation in acute severe COVID-19 pneumonia is safe for subjects and healthcare workers and could reduce the length of hospitalization stay, especially in those that may start early.
Sections du résumé
Background
UNASSIGNED
Rehabilitation in subjects with severe coronavirus disease 2019 (COVID-19) pneumonia has been widely recommended. However, data regarding the starting time of rehabilitation, subjects and healthcare workers' safety, as well as rehabilitation program features are limited. We aimed to assess the safety and characterize the effect of early and non-early physiotherapy on severe COVID-19 pneumonia subjects.
Methods
UNASSIGNED
A retrospective cohort study, including a consecutive sample of surviving subjects admitted to an acute care hospital due to severe COVID-19 pneumonia from March 13th to May 15th of 2020, is made. Subjects were separated into three groups: non-physical therapy, early physiotherapy (onset <7 days of admission), and non-early physiotherapy. Subject and therapist safety and length of hospital stay were the main evaluated outcomes.
Results
UNASSIGNED
A total of 159 subjects were included (72% men; median age 62 years). Rehabilitation was performed on 108 subjects (32 early and 76 non-early physiotherapies). The length of hospital stay was 19 [interquartile range (IQR) 36.25] and 34 days (IQR 27.25) (
Conclusion
UNASSIGNED
Rehabilitation in acute severe COVID-19 pneumonia is safe for subjects and healthcare workers and could reduce the length of hospitalization stay, especially in those that may start early.
Identifiants
pubmed: 35479948
doi: 10.3389/fmed.2022.866055
pmc: PMC9035928
doi:
Types de publication
Journal Article
Langues
eng
Pagination
866055Informations de copyright
Copyright © 2022 Bordas-Martínez, Luzardo-González, Arencibia, Tormo, Matéu, Vicens-Zygmunt, Bermudo, Santos, Molina-Molina, Planas and Suarez-Cuartín.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Phys Rehabil Med. 2020 Oct;56(5):642-651
pubmed: 32705860
Monaldi Arch Chest Dis. 2020 Mar 26;90(1):
pubmed: 32236089
Chronic Dis Transl Med. 2020 May 14;6(2):79-86
pubmed: 32411496
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
J Infect Dis. 2022 May 4;225(9):1561-1568
pubmed: 32301491
Chin Med J (Engl). 2020 Jul;133(13):1595-1602
pubmed: 32251002
Hong Kong Med J. 2009 Dec;15 Suppl 8:21-3
pubmed: 20393208
Chest. 2020 Sep;158(3):999-1007
pubmed: 32304774
ERJ Open Res. 2021 May 31;7(2):
pubmed: 34095290
Chest. 2005 Jun;127(6):2119-24
pubmed: 15947329
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
JAMA. 2013 Oct 16;310(15):1591-600
pubmed: 24108501
Respiration. 2021;100(5):416-422
pubmed: 33784696
Am J Phys Med Rehabil. 2020 Jun;99(6):468-469
pubmed: 32437114
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Am J Phys Med Rehabil. 2020 Oct;99(10):865-869
pubmed: 32732746
J Korean Med Sci. 2018 May 10;33(24):e169
pubmed: 29892209
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Thorax. 1999 Jul;54(7):581-6
pubmed: 10377201
Medicine (Baltimore). 2018 Aug;97(34):e11775
pubmed: 30142763
Physiotherapy. 2020 Jun;107:1-10
pubmed: 32135387
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Radiology. 2003 Sep;228(3):810-5
pubmed: 12805557
J Physiother. 2020 Apr;66(2):73-82
pubmed: 32312646
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
Eur J Phys Rehabil Med. 2020 Oct;56(5):633-641
pubmed: 32667150
Physiother Res Int. 2020 Jan;25(1):e1823
pubmed: 31762162
Chin Med J (Engl). 2020 May 5;133(9):1087-1095
pubmed: 32358325
Crit Care Med. 2009 Oct;37(10 Suppl):S299-308
pubmed: 20046114
Br J Sports Med. 2020 Aug;54(16):949-959
pubmed: 32475821
Influenza Other Respir Viruses. 2018 Sep;12(5):643-648
pubmed: 29676537
Respir Res. 2018 May 25;19(1):101
pubmed: 29801506
Arch Phys Med Rehabil. 2021 May;102(5):835-842
pubmed: 33166525
Ann Am Thorac Soc. 2017 May;14(5):766-777
pubmed: 28231030
Crit Care. 2021 Jan 6;25(1):16
pubmed: 33407707
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
Lancet. 2021 Aug 28;398(10302):747-758
pubmed: 34454673
J Intensive Care Soc. 2015 May;16(2):126-136
pubmed: 28979394
Respir Care. 2021 Mar;66(3):482-493
pubmed: 32934102
Eur J Phys Rehabil Med. 2020 Jun;56(3):347-353
pubmed: 32316718
Arch Phys Med Rehabil. 2021 Jun;102(6):1067-1074
pubmed: 33548208
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Am J Respir Crit Care Med. 2020 May 15;201(10):1294-1297
pubmed: 32200645
Ann Am Thorac Soc. 2021 Jan;18(1):122-129
pubmed: 32915072
Eur Respir J. 2020 Jun 18;55(6):
pubmed: 32381497